Clinical trial
A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer
NCT00475670 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00475670 |
|---|---|
| Title | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer |
| Official title | An Open-label Study of the Effect of First-line Herceptin Alone or in Combination With a Taxane on Tumor Response and Disease Progression in Patients With Metastatic Breast Cancer Who Relapsed After Receiving Adjuvant Herceptin for HER2-positive Early Breast Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Trastuzumab, Taxane (docetaxel or paclitaxel) |
| Enrollment | 44 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | May 21, 2007 |
| Last update posted | Sep 15, 2014 |
| Countries | Australia, Austria, Belgium, Brazil, Canada, China, Germany, Hungary, Italy, Mexico, Panama, Poland and 3 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: